Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Stereotaxis, Inc. on May 15, 2025. The report was filed on May 16, 2025. The company is incorporated in Delaware and its common stock trades on NYSE American LLC under the symbol STXS.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
At the Annual Meeting, 63,792,419 shares were represented, constituting a 59% quorum. The following matters were voted upon:
- Election of Directors: Two Class III directors were elected to serve until the 2028 Annual Meeting.
- Dr. Nathan Fischel: 43,049,508 votes For; 2,243,186 votes Withheld.
- Mr. Ross B. Levin: 42,319,392 votes For; 2,973,302 votes Withheld.
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2025 was ratified.
- Votes For: 63,627,003
- Votes Against: 126,608
- Votes Abstain: 38,808
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of outstanding shares (85,979,662) and the quorum percentage (59%) to assess shareholder engagement.
- Confirm the tenure of the newly elected directors (Dr. Fischel and Mr. Levin) extends through the 2028 Annual Meeting.
- Note the significant number of broker non-votes (18,499,725) recorded for the director elections.
- Review the low number of votes against the auditor ratification (126,608) relative to votes for (63,627,003).